Cordyceps CS-4 vs Cordyceps Militaris: What European Supplement Brands Need to Know

Introduction: Why the CS-4 vs Militaris Distinction Matters

If you are developing a cordyceps supplement for the European market, the first decision you face is not dosage, format, or packaging. It is which type of cordyceps to use.

That sounds straightforward. It is not.

The term “cordyceps” covers over 600 species. Two dominate the supplement industry: Cordyceps sinensis (and its CS-4 mycelium strain) and Cordyceps militaris. They are different species with distinct active compound profiles, production methods, and — critically for European brands — regulatory statuses under EU Novel Food rules.

Most of the content on this topic online conflates the two, or ignores the regulatory dimension entirely. That is a problem if you are building a brand in Europe, where getting the novel food question wrong can result in product seizure, forced market withdrawal, and tens of thousands of euros in wasted inventory.

This article covers the biology, chemistry, regulation, and tactical decision framework. It is written for B2B supplement buyers, formulators, and brand founders who need to get this right before they commit to a formulation.

What Is Cordyceps CS-4

Origin and History

Wild Cordyceps sinensis (Ophiocordyceps sinensis in current taxonomy) is a parasitic fungus found at high altitudes in the Tibetan Plateau and Himalayan regions. It has been used in Traditional Chinese Medicine for centuries, valued for its role in supporting energy, respiratory function, and general vitality.

The problem with wild sinensis is scarcity. Overharvesting and climate change have made it one of the most expensive biological materials on earth — exceeding the price of gold per gram. This made commercial production of supplements from wild Cordyceps sinensis impossible at any reasonable scale.

In the 1980s, Chinese researchers at the Institute of Materia Medica isolated a mycelial strain from wild specimens of Cordyceps sinensis. This strain, designated CS-4 (Paecilomyces hepiali), was selected because its bioactive profile most closely matched that of the wild organism. It became the basis for virtually all clinical research on cordyceps supplements over the following four decades.

How CS-4 Is Produced

CS-4 is produced through submerged liquid fermentation — a controlled industrial process where the mycelium grows in nutrient-rich liquid media inside sterile bioreactors. There is no fruiting body involved. The mycelium is harvested, dried, and processed into a standardised extract powder.

This production method has several advantages for supplement manufacturers:

• Consistency — every batch is produced under identical, controlled conditions, resulting in predictable bioactive content
• Scalability — fermentation can be scaled to meet commercial demand without the limitations of agricultural cultivation
• Standardisation — CS-4 extracts are routinely standardised to specific levels of beta-glucans, cordycepin, and adenosine
• Purity — no substrate residue (grain starch) in the final product, unlike some fruiting body preparations grown on grain

The Sinensis Blend

One detail often overlooked: CS-4 is not pure sinensis mycelium. It is a sinensis blend, containing approximately 40% militaris material. This is a natural consequence of the fermentation process and the strain’s genetic profile. It does not diminish the product — the blend has been the subject of most clinical studies — but it is worth understanding when comparing CS-4 to pure militaris preparations.

What Is Cordyceps Militaris

A Separate Species

Cordyceps militaris is a distinct species from Cordyceps sinensis. While both belong to the broader Cordyceps genus, they differ in morphology, cultivation requirements, and bioactive compound profiles.

Unlike wild sinensis, militaris can be cultivated reliably and affordably. It is typically grown on a grain or rice substrate in controlled indoor environments and — unlike CS-4 — produces a true fruiting body. This makes it attractive to brands that prefer fruiting-body-derived ingredients, which carry a stronger consumer perception in some markets.

Active Compound Profile

Militaris is often cited as having higher cordycepin content than wild sinensis. This is generally accurate — Cordyceps militaris is the primary natural producer of cordycepin (3′-deoxyadenosine), and well-optimised cultivation can yield cordycepin concentrations that exceed those found in CS-4 extracts.

However, militaris typically contains lower levels of adenosine compared to CS-4. The overall nucleoside profile differs between the two, and “higher cordycepin” does not automatically mean “better extract.” It depends entirely on what your formulation requires.

Availability and Research

Militaris has become increasingly well-studied in its own right, with a growing body of research on cordycepin’s biological activity. It is more widely available as a raw material than wild sinensis, and cultivation costs have decreased significantly as production techniques have matured.

That said, the majority of the historical clinical research on cordyceps supplements — particularly the human trials on exercise performance, respiratory function, and energy metabolism — was conducted using CS-4, not militaris. This distinction matters when substantiating product claims.

Active Compounds Compared

The table below compares the key bioactive markers in CS-4 and militaris extracts. These values represent what is achievable with properly produced, standardised cordyceps extracts — not theoretical maximums from laboratory conditions.

A note on polysaccharides: total polysaccharide content is frequently cited as a quality marker for mushroom extracts. It should not be. Polysaccharide measurements capture everything from genuine immunomodulatory beta-glucans to inactive starches from grain substrate. Beta-glucans measured by enzymatic assay (such as Megazyme K-YBGL) are the meaningful metric. We cover this in detail in our article on why polysaccharides and extraction ratios are not reliable quality markers.

EU Novel Food Status — The Critical Difference

This is the section that matters most for European supplement brands. The regulatory status of your cordyceps ingredient under EU Novel Food Regulation (EU 2015/2283) determines whether you can legally sell your product — full stop.

How Novel Food Classification Works

Under EU law, any food or food ingredient that was not consumed “to a significant degree” within the EU before 15 May 1997 is classified as a Novel Food. Novel Foods require pre-market authorisation from the European Food Safety Authority (EFSA) before they can be sold. This process typically takes 18-24 months and costs upwards of six figures.

The European Commission maintains a Novel Food Catalogue — a non-exhaustive, indicative database that records the novel food status of various ingredients. It is the primary reference point for enforcement authorities across member states.

Cordyceps Sinensis (Including CS-4)

Based on current entries in the EU Novel Food Catalogue, Cordyceps sinensis has a recognised history of consumption in food supplements in the EU before 1997. This means that, according to the catalogue, sinensis-derived preparations — including CS-4, which is classified as a sinensis mycelium strain — are not considered novel for use in food supplements.

This does not mean CS-4 is universally “approved” — there is no positive approval list for food supplements at EU level. Rather, it means there is a documented basis to argue that CS-4 falls outside the scope of the Novel Food regulation. For supplement brands, this represents the clearer regulatory pathway.

Cordyceps Militaris

The regulatory position for Cordyceps militaris is more nuanced and has been subject to varying interpretations.

The EU Novel Food Catalogue distinguishes between different parts of the organism. The status can differ depending on whether you are using the mycelium or the fruiting body, and whether the preparation is intended as a food supplement or a food ingredient in a broader sense.

While some interpretations suggest that militaris mycelium may have a history of use in supplements, the status of the fruiting body has been subject to greater regulatory scrutiny. Several EU member states have taken differing positions on militaris preparations, and the situation continues to evolve.

The practical consequence is that if you choose militaris, you need to do more regulatory homework. This may include obtaining a legal opinion, documenting history of consumption, or — in a worst case — pursuing a Novel Food application.

What This Means for Your Business

Important caveat: The Novel Food Catalogue is an indicative tool, not a legally binding instrument. Individual EU member states retain the authority to interpret and enforce novel food rules within their own jurisdictions. The entries can and do change over time. We strongly recommend that any brand bringing a cordyceps product to market in the EU obtains professional regulatory advice specific to their target markets.

For a deeper understanding of how novel food regulation applies to the full range of functional mushroom species, read our Novel Food and Functional Mushrooms guide.

Which Should You Choose — A Decision Framework

There is no universally correct answer. The right choice depends on your product, your market, and your risk tolerance. Here is how to think about it:

Choose CS-4 if:

• You want the clearest regulatory path in the EU. Based on current Novel Food Catalogue entries, CS-4’s status as a sinensis mycelium preparation gives you a stronger foundation for compliance arguments.
• You are formulating for sports nutrition or energy. The majority of human clinical trials on cordyceps and exercise performance used CS-4. If you are positioning your product around performance claims (within EFSA limits), CS-4 gives you a more substantive research base to draw from.
• You need high beta-glucan content. Our CS-4 extract is standardised to >34% beta-glucans — a level that is consistent and verifiable batch to batch.
• You value adenosine content. CS-4 delivers >0.5% adenosine, which contributes to the cardiovascular and energy-modulating effects associated with cordyceps.
• You are building a brand that needs to reference clinical research. The CS-4 literature is deeper and more extensive.

Choose Militaris if:

• You want maximum cordycepin content. Cordyceps militaris is the primary natural producer of cordycepin and can achieve higher concentrations than CS-4 under optimised cultivation conditions.
• You prefer fruiting body-derived ingredients. Militaris produces a true fruiting body, which carries stronger consumer perception in markets where “whole mushroom” positioning is valued.
• You have regulatory counsel in place. If you have already obtained a legal opinion or history-of-use documentation supporting militaris in your target EU markets, the regulatory risk is mitigated.
• Your target market is outside the EU (or in a member state with clear regulatory precedent for militaris). In the UK, USA, and several other markets, militaris does not carry the same regulatory complexity.

Regarding Cost

Both CS-4 and militaris are available at competitive B2B pricing. The per-kilogram cost depends on the standardisation level, order volume, and format (bulk powder vs encapsulated). Contact us for a detailed quote based on your specific requirements.

Quality Markers: What to Look for on a COA

Whether you choose CS-4 or militaris, the quality of your extract is defined by what is on the Certificate of Analysis — and by how that analysis was performed. Not all testing methods are equal.

The Markers That Matter

• Beta-glucans (enzymatic method) — Measured using the Megazyme K-YBGL assay or equivalent enzymatic method. This distinguishes genuine fungal beta-glucans from non-active polysaccharides. A UV spectrophotometric result for “total polysaccharides” is not the same as, and should not be accepted as a substitute for, a direct measurement.
• Cordycepin (HPLC) — High-Performance Liquid Chromatography is the standard for quantifying cordycepin. Look for a specific cordycepin value, not a bundled “total nucleosides” figure.
• Adenosine (HPLC) — Same analytical method. Particularly relevant for CS-4, where adenosine is a key differentiating marker.
• Heavy metals panel — Lead, cadmium, arsenic, mercury. Results should comply with the EU limits set by Commission Regulation 2023/915.
• Microbial testing — Total plate count, yeast and mould, coliforms, E. coli, Salmonella.

What to Avoid

• Polysaccharide content as the primary quality marker. Total polysaccharides include starches and other non-active sugars. An extract that claims “50% polysaccharides” without specifying beta-glucans separately is hiding something — or does not understand the difference.
• Extraction ratios (DER) as quality claims. A “10:1 extract” tells you the input-to-output ratio of raw material to finished extract. It does not tell you what is actually in the extract. Two 10:1 extracts from different suppliers can have wildly different bioactive profiles. Focus on what the COA says, not the ratio on the label.
• In-house COAs without independent verification. Always ask whether the COA was generated by the supplier’s own laboratory or by an independent, ISO 17025-accredited facility. Our extracts are dual-tested at independent laboratories using HPLC for species-specific markers.

Common Misconceptions

“CS-4 is synthetic”

No. CS-4 is produced by fermentation — a biological process. The mycelium is a living organism, grown from a strain isolated from wild Cordyceps sinensis. Fermentation is used across the food and supplement industry (think: probiotics, citric acid, many B vitamins). There is nothing synthetic about CS-4. It is a standardised, controlled method of producing a natural organism.

“Militaris is always better”

Not necessarily. Militaris can achieve higher cordycepin levels, but CS-4 delivers higher adenosine and has a broader nucleoside profile. CS-4 also has a deeper clinical evidence base. “Better” depends on what you are optimising for — cordycepin concentration, overall bioactive breadth, regulatory simplicity, or research substantiation.

“All Cordyceps extracts are Novel Food in the EU”

Incorrect. Based on current EU Novel Food Catalogue entries, Cordyceps sinensis preparations used in food supplements are not classified as novel. The novel food status depends on the species, the part of the organism used, and the intended application. Blanket statements about “cordyceps being novel food” oversimplify and can lead to poor sourcing decisions.

“Fruiting body is always superior to mycelium”

This is a common narrative in the mushroom supplement industry, and for most species, there is a legitimate argument for fruiting-body superiority. But Cordyceps is the exception. CS-4 mycelium produced by submerged fermentation has a well-documented bioactive profile, extensive clinical research, and — unlike some mycelium-on-grain preparations — no grain substrate residue. The fruiting body vs mycelium debate does not apply Cordycepseps the same way it applies to lion’s mane or Reishi.

Why FunctionalMushrooms.eu Supplies Both

We supply both Cordyceps CS-4 and Cordyceps militaris because different products require different ingredients. There is no single “best” cordyceps — there is the right cordyceps for your specific formulation, regulatory environment, and brand positioning.

Our Cordyceps CS-4 extract is standardised to >34% beta-glucans, >1.5% cordycepin, and >0.5% adenosine. It is produced by submerged fermentation, sourced from Asia, and dual-tested in independent laboratories using HPLC for quantification of cordycepin and adenosine. Recommended daily dose: 900mg.

Cordyceps militaris is available on request for brands that require pure militaris — whether for cordycepin maximisation, fruiting body positioning, or specific market requirements.

Both are available as bulk powder (MOQ: 5 kg) or as finished white-label capsules (MOQ: 250 units). Full COAs are available for review.

Conclusion

The CS-4 vs militaris question is not a quality question — it is a strategic one. Both are legitimate, well-characterised cordyceps ingredients with distinct advantages.

For most European supplement brands entering the cordyceps space, CS-4 offers the clearer path: a recognised regulatory position, a deep clinical research base, consistent bioactive standardisation, and competitive pricing. Militaris is a strong option for brands with specific regulatory guidance, a fruiting body positioning strategy, or a formulation that prioritises maximum cordycepin content.

Whichever you choose, the quality markers are the same: beta-glucans by enzymatic assay, cordycepin and adenosine by HPLC, independent third-party testing, and a supplier who understands both the product and the regulatory landscape.

If you are developing a cordyceps supplement and want to discuss which option fits your product, get in touch. We are happy to walk you through the specs, share COAs, and help you make the right sourcing decision for your brand.